{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:39:24Z","timestamp":1793176764840,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020193","name":"Novartis Pharmaceuticals Australia Pty Ltd","doi-asserted-by":"publisher","award":["77658903"],"award-info":[{"award-number":["77658903"]}],"id":[{"id":"10.13039\/100020193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacl.2026.08.011","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:37:48Z","timestamp":1787585868000},"page":"2172-2179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal aspects and implications of the measurement of lipoprotein(a) in patients with acute myocardial infarction"],"prefix":"10.1016","volume":"20","author":[{"given":"Seyed Saeed","family":"Tamehri Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-6948","authenticated-orcid":false,"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-5197","authenticated-orcid":false,"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-4673","authenticated-orcid":false,"given":"Graham S.","family":"Hillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-4361","authenticated-orcid":false,"given":"Carl J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-7314","authenticated-orcid":false,"given":"Nick S.R.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.08.011_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-016-6648-3","article-title":"Human genetics and the causal role of lipoprotein(a) for various diseases","volume":"30","author":"Kronenberg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacl.2026.08.011_bib2","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.011_bib3","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein (a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.011_bib4","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein (a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.08.011_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1042\/BCJ20240037","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"481","author":"Boffa","year":"2024","journal-title":"Biochem J"},{"key":"10.1016\/j.jacl.2026.08.011_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hlc.2022.11.015","article-title":"Australian Atherosclerosis Society Position Statement on lipoprotein (a): clinical and implementation recommendations","volume":"32","author":"Ward","year":"2023","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacl.2026.08.011_bib7","doi-asserted-by":"crossref","first-page":"15531","DOI":"10.3390\/ijms242115531","article-title":"Changes in lipoprotein (a) levels in people after ST elevation myocardial infarction\u2014the STEMI-lipids study","volume":"24","author":"Sourij","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2026.08.011_bib8","doi-asserted-by":"crossref","first-page":"oead035","DOI":"10.1093\/ehjopen\/oead035","article-title":"Lipoprotein (a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up","volume":"3","author":"Ziogos","year":"2023","journal-title":"Eur Heart Open"},{"key":"10.1016\/j.jacl.2026.08.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2022.01.058","article-title":"The trajectory of lipoprotein(a) during the peri- and early postinfarction period and the impact of proprotein convertase subtilisin\/kexin type 9 inhibition","volume":"171","author":"Vavuranakis","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0004563214559221","article-title":"Serum lipoprotein(a) concentrations do not change significantly in the immediate seven-day period post myocardial infarction","volume":"52","author":"Patel","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacl.2026.08.011_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijcard.2015.03.211","article-title":"Variation of lipoprotein (a) plasma levels after premature myocardial infarction","volume":"186","author":"Goliasch","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib12","first-page":"16959","article-title":"Changes in lipoprotein (a) concentrations in patients with acute coronary syndrome","volume":"135","author":"Sata\u0142a","year":"2025","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jacl.2026.08.011_bib13","first-page":"15","article-title":"Intra-individual variability of lipoprotein(a) after acute coronary syndrome: a long-term cohort study","volume":"2026","author":"Gonz\u00e1lez-Aguado","year":"1938","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2026.08.011_bib14","article-title":"Is it time to rethink the single lifetime measurement of lipoprotein(a)?","volume":"1","author":"Augusto","year":"2026","journal-title":"Adv Lipoprotein(a) Res"},{"key":"10.1016\/j.jacl.2026.08.011_bib15","doi-asserted-by":"crossref","DOI":"10.15420\/japsc.2024.28","article-title":"Lipoprotein(a) may be falsely lowered when troponin T is elevated in patients with ischaemic heart disease during acute admissions","volume":"4","author":"Yeo","year":"2025","journal-title":"JAPSC"},{"key":"10.1016\/j.jacl.2026.08.011_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5114\/aoms\/188252","article-title":"Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction","volume":"20","author":"Zimodro","year":"2024","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jacl.2026.08.011_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamacardio.2020.5398","article-title":"Clinical utility of lipoprotein (a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease","volume":"6","author":"Trinder","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/eurjpc\/zwae100","article-title":"Association between lipoprotein(a), LPA genetic risk score, aortic valve disease, and subsequent major adverse cardiovascular events","volume":"31","author":"Moore","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2018.12.037","article-title":"Value of measuring lipoprotein(a) during cascade testing for familial hypercholesterolemia","volume":"73","author":"Ellis","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib21","first-page":"ehaf677","article-title":"Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study","volume":"31","author":"Kindborg","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.011_bib22","article-title":"Cascade testing for elevated lipoprotein (a) in relatives of probands with high lipoprotein (a)","volume":"10","author":"Chakraborty","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2021.11.004","article-title":"Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)","volume":"349","author":"Chakraborty","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.011_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.011_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacl.2017.10.024","article-title":"Temporal variability in lipoprotein (a) levels in patients enrolled in the placebo arms of IONIS-APO (a) Rx and IONIS-APO (a)-LRx antisense oligonucleotide clinical trials","volume":"12","author":"Marcovina","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.011_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2024.10.081","article-title":"Intraindividual variability in serial lipoprotein (a) concentrations among placebo-treated patients in the OCEAN (a)-DOSE trial","volume":"85","author":"Gaba","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurheartj\/ehae652","article-title":"Within-person stability of lipoprotein (a) concentration","volume":"46","author":"Ghouse","year":"2025","journal-title":"Eur Herat J"},{"key":"10.1016\/j.jacl.2026.08.011_bib28","doi-asserted-by":"crossref","first-page":"oeae064","DOI":"10.1093\/ehjopen\/oeae064","article-title":"Intra-individual variability in lipoprotein (a): the value of a repeat measure for reclassifying individuals at intermediate risk","volume":"4","author":"Harb","year":"2024","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.jacl.2026.08.011_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026762","article-title":"Temporal trends in lipoprotein(a) concentrations: the atherosclerosis risk in communities study","volume":"11","author":"Deshotels","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.08.011_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2021.11.055","article-title":"Repeat measures of lipoprotein(a) molar concentration and cardiovascular risk","volume":"79","author":"Trinder","year":"2022","journal-title":"J Am Coll CardioL"},{"key":"10.1016\/j.jacl.2026.08.011_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurjpc\/zwae341","article-title":"Intra-individual variability in lipoprotein (a) levels: findings from a large academic health system population","volume":"32","author":"Awad","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.102601","article-title":"Intraindividual Lp(a)-variability in a real-world setting","volume":"5","author":"Seidel","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacl.2026.08.011_bib33","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1161\/CIR.0000000000001457","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"153","author":"Blumenthal","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.011_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.08.011_bib35","doi-asserted-by":"crossref","first-page":"oead077","DOI":"10.1093\/ehjopen\/oead077","article-title":"Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population","volume":"3","author":"Shiyovich","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.jacl.2026.08.011_bib36","first-page":"77","article-title":"Serum lipoprotein (a) changes in acute myocardial infarction","volume":"43","author":"Motta","year":"2001","journal-title":"Panminerva Med"},{"key":"10.1016\/j.jacl.2026.08.011_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0021-9150(89)90218-9","article-title":"Transient changes of serum lipoprotein(a) as an acute phase protein","volume":"78","author":"Maeda","year":"1989","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.011_bib38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1399-0004.1994.tb04408.x","article-title":"Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction","volume":"46","author":"Andreassen","year":"1994","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2026.08.011_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.RES.78.4.615","article-title":"Specific accumulation of lipoprotein (a) in balloon-injured rabbit aorta in vivo","volume":"78","author":"Nielsen","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2026.08.011_bib40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein (a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jacl.2026.08.011_bib41","doi-asserted-by":"crossref","first-page":"S506","DOI":"10.1016\/j.hlc.2024.06.829","article-title":"Absence of association between plasma lipoprotein(a) and high-sensitivity C-reactive protein at time of acute mycardial infarction","volume":"33","author":"Lan","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacl.2026.08.011_bib42","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.011_bib43","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamacardio.2023.3548","article-title":"Concordance of a high lipoprotein (a) concentration among relatives","volume":"8","author":"Reeskamp","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MOL.0000000000000951","article-title":"Effectiveness of cascade screening for elevated lipoprotein (a), an underdiagnosed family disorder","volume":"35","author":"Annink","year":"2024","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.011_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120447","article-title":"Lp(a) international taskforce (ITF) initiative. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis","volume":"409","author":"Morton","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.011_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/clc.22880","article-title":"Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: between Scylla and Charybdis","volume":"41","author":"Ellis","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacl.2026.08.011_bib47","article-title":"Novel method for predicting lp(a) from genomic testing identifies ascvd risk across a diverse cohort","volume":"10","author":"Telis","year":"2025","journal-title":"JACC Basic Transl Sci"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600485X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600485X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:26:44Z","timestamp":1793176004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742600485X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S193328742600485X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.011","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal aspects and implications of the measurement of lipoprotein(a) in patients with acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}